118ͼ¿â

Dr Anna Wilkins is a Clinician Scientist at the Institute of Cancer Research, London, and an Honorary Consultant in Clinical Oncology at the Royal Marsden, where she treats prostate and bladder cancers. Anna’s research combines human translational science with pre-clinical models to investigate how different features of the tumour microenvironment, including non-cancerous cells, might help prostate and bladder tumours survive after radiotherapy. 

Anna completed her undergraduate and postgraduate medical studies at the  in 2001 before travelling to Myanmar to work on a large-scale HIV/AIDS project. 

On her return to London in 2008, she underwent specialist clinical oncology training and, in 2013, was awarded a Cancer Research UK Clinical Research Training Fellowship at the ICR. While studying for her PhD, Anna led a number of projects, based on the  in prostate cancer, to develop predictive models for the efficacy and toxicity of hypofractionated radiotherapy. In 2019, Anna was awarded a Crick Postdoctoral Clinical Fellowship to pursue her research in Dr Erik Sahai’s laboratory. She continues to study the impact of radiotherapy on different aspects of the tumour microenvironment. 

« Back